ANDA 74852, held by Actavis Labs Fl Inc. Diltiazem Hydrochloride.
As of Nov 16, 2026, ANDA 74852 (Diltiazem Hydrochloride), held by Actavis Labs Fl Inc, was first approved by FDA on Oct 10, 1997, with 9 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 10, 1997 | Original application | Approved | None posted |
| Diltiazem Hydrochloride120MG · capsule, extended release;oral | Diltiazem Hydrochloride | Discontinued |
| Diltiazem Hydrochloride180MG · capsule, extended release;oral | Diltiazem Hydrochloride | Discontinued |
| Diltiazem Hydrochloride240MG · capsule, extended release;oral | Diltiazem Hydrochloride | Discontinued |
| Aug 30, 2007 | Supplement 14Labeling | Approved | None posted |
| Mar 12, 2007 | Supplement 13Labeling | Approved | None posted |
| Dec 24, 2002 | Supplement 7Manufacturing | Approved | None posted |
| Oct 11, 2002 | Supplement 6Manufacturing | Approved | None posted |
| Feb 15, 2001 | Supplement 5Manufacturing | Approved | None posted |
| Aug 16, 2000 | Supplement 4Manufacturing | Approved | None posted |
| May 16, 2000 | Supplement 3Manufacturing | Approved | None posted |
| Apr 7, 1999 | Supplement 2Manufacturing | Approved | None posted |
| Apr 7, 1999 | Supplement 1Manufacturing | Approved | None posted |
| Oct 10, 1997 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters